We illustrate the robustness and reproducibility of our experimental procedure in patients with APDS who had high Akt and/or S6 phosphorylation levels at baseline, and after anti-IgM stimulation in B cells. This evidence concerns the gene CD40LG and activated PI3K-delta syndrome.